https://sant-1antagonist.com/c....odon-project-evolvab
Our research focused on dissecting IPF into subtypes via metabolic pathways and evaluating prospective drug candidates for each distinct subtype. Gene profiles, along with clinical details, were acquired from the Gene Expression Omnibus (GEO) database's GSE70867 and GSE93606 datasets. Employing the Gene Set Variation Analysis (GSVA) package, enrichment scores were determined for 41 metabolism-related pathways, immune cells, and immune pathways. To achieve sample clustering, the ConsensusCl
Like
Comment
Share
